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A B S T R A C T
Human cytomegalovirus (HCMV) is a widespread pathogen that infects up to 80% of the human
population and causes severe complications in immunocompromised patients. HCMV expresses four
seven transmembrane (7TM) spanning/G protein-coupled receptors (GPCRs) – US28, US27, UL33 and
UL78 – that show close homology to human chemokine receptors. While US28 was shown to bind several
chemokines and to constitutively activate multiple signaling cascades, the function(s) of US27, UL33 and
UL78 in the viral life cycle have not yet been identiﬁed. Here we investigated the possible interaction/
heteromerization of US27, UL33 and UL78 with US28 and the functional consequences thereof. We
provide evidence that these receptors not only co-localize, but also heteromerize with US28 in vitro.
While the constitutive activation of the US28-mediated Gaq/phospholipase C pathway was not affected
by receptor heteromerization, UL33 and UL78 were able to silence US28-mediated activation of the
transcription factor NF-kB. Summarized, we provide evidence that these orphan viral receptors have an
important regulatory capacity on the function of US28 and as a consequence, may ultimately impact on
the viral life cycle of HCMV.
  2011  Elsevier  Inc.  
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Human cytomegalovirus (HCMV), also known as human
herpesvirus 5 (HHV-5), is a large and highly species-speciﬁc virus
that belongs to the family of beta-herpesviruses. Infection with
HCMV is asymptomatic and rarely causes complications in
immunocompetent hosts. In immunosuppressed hosts, however,
HCMV infection causes severe complications, including graft
rejection or systemic infections [1–4]. HCMV expresses four viral
seven transmembrane (7TM) spanning/G protein-coupled recep-
tors (GPCRs), i.e. UL33 (unique long 33), UL78, US27 (unique short
27) and US28, which show high homology to human chemokine
receptors [5,6].
US28 is the best characterized HCMV encoded 7TM/GPCR and
was suggested to (i) be important for the viral life cycle by
enhancing cell–cell fusion, thus promoting viral spread [7–10] and
(ii) to activate the immediate early HCMV promoter, which
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dent way. The receptor activates the Gaq/phospholipase C (PLC)
pathway and induces several transcription factors, such as NF-kB
(nuclear factor kappa B), CREB (cyclic AMP responsive element
binding) [12,13], NFAT (nuclear factor of activated T cells) [14] or
SRF (serum response factor) [15]. Moreover, US28 is constitutively
endocytosed, which results in the localization of the receptor in the
membranes of intracellular organelles, especially late endosomes/
lysosomes and multi-vesicular bodies (MVBs) [13,16,17], where it
has been suggested that the virions of HCMV may be assembled
[7,8].
US27, UL33 and UL78 are still ‘‘orphan’’ receptors, since no
endogenous ligands have been identiﬁed to date. Of these, UL33
was reported to constitutively induce inositol phosphate (IP)
accumulation via coupling to Gaq and Gai/o-proteins [13,18] and
to activate CREB via Gaq, Gas, Gbg and p38 kinase [13,18], as well
as to co-localize with endosomes in HCMV infected cells [7,8].
US27 was shown to be expressed during late HCMV infection
states and found to be present on HCMV virions [7,19,20]. UL78
shares only very limited homology with endogenous chemokine
receptors [21] and was shown to be dispensable for viral
replication [22].
Orphan 7TM/GPCRs have recently been shown to inﬂuence the
signal activity of non-orphan receptors through heteromerization.
One prominent example is the orphan receptor GPR50, which was
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receptor. Heteromerization of GPR50 with the MT1 receptor
prevented the agonist binding and G protein coupling [23].
Here we set out to test whether the orphan viral receptors US27,
UL33 and UL78 possibly interact/heteromerize with US28 and
whether this had functional consequences on the signaling and/or
endocytic properties of US28.
2. Materials and methods
2.1. Reagents
Mouse anti-Flag M1 and M2 monoclonal antibody, gelatine
from bovine skin Type B, Triton X-100, 3,30,5,50-tetramethylbenzi-
dine liquid substrate system were purchased from Sigma–Aldrich
(Austria). Cell culture media (DMEM), fetal bovine serum (FBS),
Dulbecco’s phosphate buffered saline (DPBS), Lipofectamine 2000,
Alexa Fluor 594 nm conjugated IgG1a, 488 nm conjugated IgG2b
and 594 nm conjugated donkey anti rabbit IgG were purchased
from Invitrogen (Austria). HRP-conjugated anti-mouse antibody
was obtained from Jackson Immuno Research (Dianova, Germany).
Vectashield mounting medium and Vectastain ABC Kit were
purchased from Vector Laboratories (Szabo-Scandic, Austria). The
white 96-well culture plates and the Steadylite Plus Assay Kit, high
sensitivity luminescence reporter gene assay system, [3H]myo-
inositol and EasyTag 35S-methionine were purchased from
PerkinElmer (Austria). Yttrium silicate (YSi) SPA beads were from
GE Healthcare (Austria). NaOH, KCl and CaCl22H2O were obtained
from Merck (Austria), NaCl, Tris and formaldehyde were from Roth
(Lactan, Austria). Coelenterazine-H powder (1 mg) was purchased
from Interchim (France). Monoclonal rat anti-HA and monoclonal
mouse anti-GFP antibodies were purchased from Roche Diagnos-
tics (France). Monoclonal rabbit anti-HA antibody was purchased
from Cell Signaling (France). Polyclonal rabbit anti-Flag antibody,
protein G sepharose beads and poly-L-lysine were obtained from
Sigma–Aldrich (France). Phusion High-Fidelity DNA Polymerase
was purchased from Finnzymes (France). IRdye 800-conjugated
anti-rat, IRdye 680-conjugated anti-rabbit, IRdye680-conjugated
anti-mouse antibodies were purchased from Thermo Scientiﬁc
(France). JetPEI transfection reagent was obtained from Polyplus
Transfection (France).
2.2. DNA constructs
A Flag-tagged version of US28 (Flag-US28) was cloned by using
the BamHI and XbaI restriction sites in the SS-Flag pcDNA3.1 zeo
(+) vector (16). The cDNA encoding UL78 was kindly provided by
Dr. Detlef Michel (University of Ulm, Germany) and was cloned in
the SS-Flag pcDNA3.1 zeo (+) and SS-HA pcDNA3.1 zeo (+) vectors
using BamHI and EcoRV restriction sites. UL33 (exon 1 + 2) was
cloned in the SS-HA pcDNA3.1 zeo (+) vector using BamHI and XhoI
restriction sites. A HA-tagged version of US27 (exon 2) was cloned
by using the BamHI and EcoRV restriction sites in SS-HA pcDNA3.1
zeo (+) vector. Flag-US28-YFP, HA-US28-Rluc, HA-UL33, HA-UL33-
Rluc, Flag-UL78 and HA-UL78-Rluc constructs were obtained using
the latter cDNAs as templates and the Phusion High-Fidelity DNA
Polymerase. The Flag or HA tags were inserted after the ATG in
frame of the US28, UL33 or UL78 sequences. Flag-US28, HA-US28,
HA-UL33, Flag-UL78 and HA-UL78 were ampliﬁed by PCR. The
ampliﬁed products were subcloned directly into a pCR2.1 vector
(Invitrogen, CA). After sequencing, the fragments were digested
with the restriction enzymes HindIII and BamHI and subcloned
into pcDNA3.1 vector or pcDNA3.1 vector containing either YFP or
Rluc sequences. The vasopressin V2-YFP fusion protein has been
described previously [24]. All DNA constructs were veriﬁed by
sequencing.2.3. Antibody feeding experiments
HEK293 cells were grown on gelatin coated coverslips and
transiently transfected with Flag-US28 (1.5 mg/coverslip) in
combination with HA-UL33 (1.5 mg/coverslip), HA-UL78 (1.5 mg/
coverslip) or HA-US27 (1.5 mg/coverslip) using Lipofectamine
2000. 24 h post-transfection, antibody feeding experiments were
conducted essentially as previously described [25]. In brief, living
cells were incubated with anti-Flag M1 (1:500) and anti-HA HA11
(1:500) antibodies for 45 min, ﬁxed with 3.7% formaldehyde in PBS
and permeabilized in blotto (50 mM Tris–HCl, pH 7.5, 1 mM CaCl2,
0.2% Triton X-100 and 3% milk). Subsequently, the cells were
stained with the subtype-selective antibodies Alexa Fluor 488-
conjugated IgG2b against the Flag-tag (1:1000, 20 min) and Alexa
Fluor 594-conjugated IgG1a against the HA-tag (1:1000, 20 min).
Finally, cells were mounted with Vectashield mounting medium
and analyzed using an Olympus IX70 ﬂuorescence microscope.
2.4. Immunoprecipitation
For co-immunoprecipitation assays, HEK293T cells were seeded
in 10 cm dishes and co-transfected with 8 mg of the indicated
plasmids. 48 h after transfection, cells were washed twice in PBS,
and lysed in 1 ml cold lysis buffer (25 mM Tris (pH 7.4), 2 mM
EDTA, 10 mM MgCl2, protease inhibitor cocktail and 1% Triton).
After solubilization for 2 h at 4 8C, lysates were centrifuged at
12,000  g during 1 h at 4 8C and the supernatant was collected for
the immunoprecipitation assay. Immunoprecipitations were
performed using 2 mg of the indicated antibodies pre-adsorbed
on protein G sepharose beads for 2 h at 4 8C. Immunoprecipitated
proteins were eluted with Laemmli buffer 2 (Tris–HCl pH 6.8,
125 mM, SDS 10%, Glycerol 10%, bromophenol blue 1% and DTT
100 mM) and subjected to 10% or 7.5% SDS–PAGE and immuno-
blotting. Immunoblotting was performed using the indicated
antibodies and immunoreactivity was revealed using secondary
antibodies coupled to 680 or 800 nm ﬂuorophores using the
Odyssey LI-COR infrared ﬂuorescent scanner (ScienceTec).
2.5. BRET (bioluminescence resonance energy transfer) measurement
HEK293T cells were grown in complete medium (Dulbecco’s
modiﬁed Eagle’s medium supplemented with 10% (v/v) fetal
bovine serum, 4.5 g/L glucose, 100 U/ml penicillin, 0.1 mg/ml
streptomycin and 1 mM glutamine) (Invitrogen, CA). Transient
transfections were performed using JetPEI transfection reagent
according to manufacturer’s instructions.
For BRET donor saturation curves, HEK293T cells were seeded in
12-well plates and transiently transfected with 200 ng of HA-
UL33-Rluc or 100 ng of HA-UL78-Rluc and 100–1800 ng of YFP
plasmids. For BRET competition assays, HEK293T cells were seeded
in 6-well plates. Cells were transiently transfected with (i) 200 ng
HA-UL33-Rluc and 1000 ng Flag-US28-YFP in the presence or
absence of 1800 ng Flag-UL78 or (ii) 100 ng HA-UL78-Rluc and
1000 ng Flag-US28-YFP in the presence or absence of 1900 ng HA-
UL33 plasmids. 24 h after transfection, cells were transferred into a
96-well white Optiplate pre-coated with 10 mg/ml poly-L-lysine.
Following 24 h incubation, BRET measurements were conducted.
Luminescence and ﬂuorescence were measured simultaneously
using the lumino/ﬂuorometer MithrasTM (Berthold) that allows the
sequential integration of luminescence signals detected with two
ﬁlter settings (Rluc ﬁlter, 485  10 nm; YFP ﬁlter, 530  12.5 nm).
Emission signals at 530 nm were divided by emission signals at
485 nm and the difference between this emission ratio (obtained with
donor and acceptor fused or co-expressed and that obtained with the
donor protein expressed alone) was deﬁned as the BRET ratio. The
results were expressed in milliBRET units (mBU) corresponding to the
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measured with the ﬂuorometer FusionTM (Packard Instrument
Company).
2.6. Reporter gene assays
Transcription factor luciferase assays were performed essen-
tially as described in Ref. [13]. In brief, HEK293 cells (30,000 cells/
well) were seeded on gelatin coated 96-well plates and transiently
transfected with 75 ng/well Flag-US28, the cis-reporter plasmid for
NF-kB (50 ng/well) and either pcDNA3.1 (75 ng/well) or the
respective receptors (HA-UL33, HA-UL78 or HA-US27; 75 ng/well).
Controls were transfected with 150 ng/well of either pcDNA3.1
alone, or pcDNA3.1 (75 ng/well) in combination with UL33, UL78
or US27 (75 ng/well), but in the absence of US28. In parallel to each
assay, an additional plate was prepared for ELISA (see below) to
control for receptor expression levels. The luciferase reporter gene
assays were conducted 24 h post-transfection according to the
manufacturer’s guidelines. In brief, cells were washed twice with
PBS and the cell number was determined by optical density in a
FlexStation II Device (Molecular Probes, Endpoint Measurement).
Then, 100 ml/well Steadylight luciferase assay reagent were added
to 100 ml/well PBS. Following a 10 min incubation period,
luminescence was measured using a TopCounter Device (TopCount
NXT, PerkinElmer).
2.7. Inositol phosphate (IP) accumulation assay
HEK293 cells were seeded on gelatin coated 96-well plates
(30,000 cells/well) and transfected with 75 ng/well Flag-US28 and
either pcDNA3.1 (75 ng/well) or the respective orphan receptor
(HA-UL33, HA-UL78 or HA-US27; 75 ng/well). Controls were
transfected with 150 ng/well of either pcDNA3.1 alone, or
pcDNA3.1 (75 ng/well) in combination with UL33, UL78 or US27
(75 ng/well), but in the absence of US28. In parallel to each assay,
an additional plate was prepared for ELISA (see below) to control
for receptor expression levels. 24 h post-transfection the cells were
loaded with 1 mCi/well [3H]myo-inositol in 100 ml/well Optimem
and incubated overnight at 37 8C and 5% CO2. The next day, the
labeling medium was aspirated, 100 ml/well HBSS buffer (includ-
ing CaCl2 and MgCl2) containing 10 mM LiCl were added and the
cells were incubated for 45 min at 37 8C and 5% CO2. The reaction
was terminated by aspiration and the cell number was determined
by optical density in a FlexStation II Device. Subsequently, cells
were lysed with 50 ml/well 10 mM formic acid for 90 min on ice.
40 ml of the resulting cell extract were transferred to 160 ml of YSi-
SPA beads (12.5 mg/ml) and shaken for 90 min at 4 8C. The plates
were then stored at 4 8C and the accumulation of inositol
phosphate was counted in a TopCount microplate scintillation
counter (TopCount NXT, PerkinElmer) 24 h later.
2.8. ELISA (enzyme linked immunosorbent assay)
The ELISAs were performed on the same day as the
corresponding signaling experiments (see above). Cells were ﬁxed
with 3.7% formaldehyde in PBS and permeabilized in blotto
(50 mM Tris–HCl, pH7.5, 1 mM CaCl2, 0.2% Triton X-100 and 3%
milk) for 1 h. Next, the cells were incubated with either anti-Flag
M1 (1:500) or anti-HA HA11 (1:1000) antibody overnight at 4 8C.
Then cells were washed with TBS (25 mM Tris base, 135 mM NaCl,
2.5 mM KCl, 1 mM CaCl22H2O, pH 7.4) and incubated with HRP-
conjugated anti-mouse antibody (1:2500) in blotto (50 mM Tris–
HCl, pH 7.5, 1 mM CaCl2 and 1.5% milk) for 2 h at room
temperature. After three washes with TBS, the cell number was
determined by optical density in a FlexStation II Device. Then,
75 ml/well TMB (3,30,5,50-tetramethylbenzidine) substrate wasadded and the coloring reaction was stopped by the addition of
50 ml/well 0.5 M sulfuric acid after 2 min at room temperature.
Receptor levels were measured at the optical density of 450 nm in
a BioRad xMark Microplate Spectrophotometer.
2.9. Statistical analysis
Statistical analyses were performed using ANOVA analysis of
variance for comparisons between multiple groups, followed by a
Bonferroni’s post-hoc analysis using GraphPad Prism software.
3. Results
3.1. Co-localization of HCMV encoded chemokine receptors
US28, UL33 and US27 have previously been shown to
constitutively internalize and localize in intracellular compart-
ments [7,13,16]. Here we set out to investigate a possible co-
localization of US28 with the three orphan HCMV encoded
receptors US27, UL33 and UL78. Therefore, the respective
receptors were transiently co-expressed with US28 in HEK293
cells at a 1:1 ratio and antibody feeding experiments were
conducted (see Section 2). These experiments revealed that US28
co-internalizes and co-localizes with UL33 (Fig. 1A) and UL78
(Fig. 1B) in HEK293 cells. As described before [26], US28 was also
found to co-localize with US27 (Fig. 1C).
3.2. Dimerization of US28 with US27, UL33 and UL78
We were able to demonstrate that after constitutive internali-
zation US28 co-localizes with all three orphan receptors in
endosomal compartments (Fig. 1). Next, we conducted co-
immunoprecipitation (co-IP) experiments to test whether the
receptors are not only co-localizing, but furthermore able to
physically interact with each other. Therefore, HEK293T cells were
transiently co-transfected with Flag-US28-YFP and HA-US28 (A),
HA-UL33-Rluc (B), HA-UL78-Rluc (C) or HA-US27 (D). These
experiments revealed that US28 not only forms homomers
(Fig. 2A), but moreover interacts with all three orphan receptors
(Fig. 2B–D).
Next, bioluminescence resonance energy transfer (BRET) assays
were performed to conﬁrm the co-IP results. Therefore, UL33 or
UL78 were fused at their C-terminus to Renilla luciferase (HA-
UL33-Rluc, HA-UL78-Rluc) and used as energy donors. US28 was
fused at its C-terminus to YFP (Flag-US28-YFP) and used as the
energy acceptor. A possible heteromerization between US28 and
US27 could not be validated using the BRET approach, since the co-
expression of US27-Rluc led to a signiﬁcant decrease in US28-YFP
expression levels (data not shown).
Donor saturation curves were performed by co-transfecting a
ﬁxed amount of HA-UL33-Rluc or HA-UL78-Rluc in the presence of
increasing amounts of Flag-US28-YFP in HEK293T cells. The
vasopressin V2 receptor YFP (V2-YFP) fusion protein was used
as a negative control. A speciﬁc interaction between BRET donor
and acceptor pairs is reﬂected by a hyperbolic donor saturation
curve, which reaches an asymptote with increasing YFP/Rluc
ratios. This is shown for the US28/UL33 couple (Fig. 3A) and the
US28/UL78 couple (Fig. 3B), respectively. In contrast, a non-speciﬁc
interaction, due to random collision, was observed with V2-YFP
where a quasi-linear increase in BRET was observed with
increasing YFP/Rluc ratios (Fig. 3B). BRET competition assays were
then performed to assess, if UL78 and UL33 can disrupt US28/UL33
and US28/UL78 heteromerization, respectively. The YFP/Rluc ratio
in the ascending portion of the saturation curve before the plateau
was selected and the corresponding amounts of donor and
acceptor plasmids were transfected in the presence of saturating
Fig. 1. US28 co-localizes with UL33, UL78 and US27. HEK293 cells transiently transfected with Flag-US28 and either HA-UL33 (A), HA-UL78 (B) or HA-US27 (C) were ‘fed’
antibody to the extracellular Flag-tag and HA-tag for 60 min. The cells were then ﬁxed and stained with the secondary antibodies under permeabilizing conditions. Finally,
cells were mounted with Vectashield (+DAPI, blue) and analyzed by ﬂuorescence microscopy. Merge: yellow. Scale bars = 10 mm. (For interpretation of the references to color
in this ﬁgure legend, the reader is referred to the web version of the article.)
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UL33-Rluc/Flag-US28-YFP and HA-UL33 in the case of HA-UL78-
Rluc/Flag-US28-YFP). The BRET signal was signiﬁcantly decreased
in the presence of the competitor receptor indicating that UL78
(Fig. 3C) and UL33 (Fig. 3D) interfere with US28/UL33 and US28/
UL78 heteromerization, respectively.
Summarized, the co-IP and BRET experiments show that US28
forms homomers and is furthermore able to heteromerize with the
three viral HCMV encoded receptors US27, UL33 and UL78.
3.3. US28-mediated transcription factor activation, but not G protein-
mediated inositol phosphate accumulation, is altered by receptor
heteromerization
It has previously been demonstrated that receptor heteromer-
ization alters the trafﬁcking and signaling properties of 7TM/
GPCRs [27–29]. Importantly, orphan receptors – such as GPR50 –have been demonstrated to modulate the activity of non-orphan
receptors through heteromerization [30].
Hence, we next tested the functional consequences of the
heteromerization of US28 with US27, UL33 and UL78. First, the
ability of US28 to mediate the Gaq/phospholipase C (PLC)
dependent accumulation of inositol phosphate (IP) was assessed
in cells co-expressing the orphan HCMV encoded receptors. US28
constitutively induced IP turnover in the absence (Fig. 4A, D and G,
black bars) and presence (Fig. 4A, D and G, grey bars) of the other
viral receptors. The expression levels of Flag-tagged US28 (Fig. 4B,
E and H) as well as the HA-tagged orphan receptors (Fig. 4C, F and I)
were monitored by ELISA. These results suggest that the orphan
receptors had no direct inﬂuence on the G protein mediated
signaling capacity of US28.
US28 has been reported to activate downstream transcription
factors such as NF-kB, CREB [12,13], NFAT [14] or SRF [15]. We next
tested whether the heteromerization of US28 with the orphan
Fig. 2. (A) Detection of US28/US28 homomers using co-immunoprecipitation. HEK293T cells were transfected with HA-US28 in the presence or absence of Flag-US28-YFP.
Lysates were immunoblotted with monoclonal rabbit anti-HA (bottom blot) and polyclonal rabbit anti-Flag antibodies (middle blot). Lysates were immunoprecipitated with
monoclonal rat anti-HA, resolved by SDS–PAGE and immunoblotted with polyclonal rabbit anti-Flag antibodies (top blot). (B) Detection of US28/UL33 heteromers using co-
immunoprecipitation. HEK293T cells were transfected with HA-UL33-Rluc in the presence or absence of Flag-US28-YFP. The expression of HA-UL33-Rluc was monitored by
measuring Renilla luciferase activity following coelenterazine H addition (bottom graph). Lysates were immunoblotted with monoclonal mouse anti-GFP antibodies (middle
blot). Lysates were immunoprecipitated with monoclonal rat anti-HA, resolved by SDS–PAGE and immunoblotted with monoclonal mouse anti-GFP antibodies (top blot). (C)
Detection of US28/UL78 heteromers using co-immunoprecipitation. HEK293T cells were transfected with HA-UL78-Rluc in the presence or absence of Flag-US28-YFP. The
expression of HA-UL78-Rluc was monitored by measuring Renilla luciferase activity following coelenterazine H addition (bottom graph). Lysates were immunoblotted with
polyclonal rabbit anti-Flag antibodies (middle blot). Lysates were immunoprecipitated with monoclonal rat anti-HA, resolved by SDS–PAGE and immunoblotted with
polyclonal rabbit anti-Flag antibodies (top blot). All immunoblots shown are representative of three independent experiments. (D) Detection of US28/US27 heteromers using
co-immunoprecipitation. HEK293T cells were transfected with HA-US27 in the presence or absence of Flag-US28-YFP to assess US27/US28 heteromer formation. Lysates
were immunoblotted with monoclonal rat anti-HA (bottom blot) and polyclonal rabbit anti-Flag antibodies (middle blot). Lysates were immunoprecipitated with monoclonal
rat anti-HA, resolved by SDS–PAGE and immunoblotted with polyclonal rabbit anti-Flag antibodies (top blot).
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Fig. 3. Heteromerization of US28 with UL33 and UL78. (A) Donor saturation curves were performed by co-transfecting a ﬁxed amount of HA-UL33-Rluc in the presence of
increasing amounts of Flag-US28-YFP in HEK 293T cells. The saturation curves are obtained from three independent experiments. (B) Donor saturation curves were performed
by co-transfecting a ﬁxed amount of HA-UL78-Rluc in the presence of increasing amounts of Flag-US28-YFP (*) in HEK 293T cells. V2-YFP (&) was used as a negative control.
The saturation curves are obtained from three independent experiments. (C) Bret competition assays were performed by co-transfecting a ﬁxed amount of HA-UL33-Rluc and
Flag-US28-YFP corresponding to a YFP/Rluc ratio in the ascending portion of the saturation curve before the plateau in the presence of saturating amounts of the competitor
receptor (Flag-UL78). Lysates were immunoblotted with polyclonal rabbit anti-Flag antibody (bottom blot) to assess the expression levels of the competitor receptor. (D) Bret
competition assays were performed by co-transfecting a ﬁxed amount of HA-UL78-Rluc and Flag-US28-YFP corresponding to a YFP/Rluc ratio in the ascending portion of the
saturation curve before the plateau in the presence of saturating amounts of the competitor receptor (HA-UL33). Lysates were immunoblotted with monoclonal rabbit anti-
HA antibody (bottom blot) to assess the expression levels of the competitor receptor. Statistical differences were assessed using the student t-test (***p < 0.001).
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tion proﬁle of US28. Hence, US28 was co-expressed with the
respective orphan receptors and reporter gene assays were
performed. Interestingly, the co-expression of UL33 and UL78
was found to signiﬁcantly decrease the activation of the
transcription factor NF-kB by US28 (Fig. 5A and D, compare black
bars vs. grey bars). The reduction of US28 signaling capacity in the
presence of UL33 and UL78 was unlikely to be due to altered
expression levels of the receptors, since they remained relatively
stable under the different experimental conditions (see Fig. 5B, C, E
and F). Co-expression of US27 on the other hand, did not alter the
signaling capacity of US28 (Fig. 5G compare black bar vs. grey bar).
Summarized, these data suggest that the constitutive signaling
activity of US28 is selectively modulated via heteromerization
with the orphan HCMV-encoded UL33 and UL78. The activation of
the Gaq/PLC/IP3 pathway via US28 was not altered, whereas the
activation of the transcription factor NF-kB by US28 was almost
completely blocked by UL33 or UL78, respectively.
4. Discussion
Out of the four HCMV encoded 7TM/GPCRs, US28 is the only
receptor that has been shown to bind endogenous chemokines[13,31,32]. The other three receptors – US27, UL33 and UL78 – are
yet orphan receptors with mainly unknown function [5,6]. Here we
tested whether these orphan receptors – similar to recent reports
on other orphan 7TM/GPCRs [23] – may have ligand-independent
functions by modulating the signaling and trafﬁcking capacities of
US28.
Antibody feeding experiments revealed that all four viral 7TM/
GPCRs are predominantly found in intracellular compartments.
This is in accordance with previous data on US27, US28 and UL33
[7,33], which have all been described to constitutively internalize.
Here we show for the ﬁrst time that US28 co-localizes with all
three orphan receptors in HEK293 cells (Fig. 1).
Heteromerization and thus a direct protein–protein interaction
between these HCMV encoded receptors were conﬁrmed by co-IP
and BRET experiments (Figs. 2 and 3). To date it is widely accepted
that most, if not all, 7TM/GPCRs are organized in dimeric/
oligomeric complexes. The importance of 7TM/GPCR oligomeriza-
tion is most convincingly illustrated by the functional alterations
induced when two different 7TM/GPCRs associate to form
heteromeric complexes. Modiﬁcations in pharmacological, signal-
ing and trafﬁcking properties have been observed for many 7TM/
GPCRs when engaged into heteromers [27–29,34]. For instance, the
chemokine receptor CXCR4 was shown to heteromerize with CCR5
Fig. 4. US28-mediated inositol phosphate (IP) accumulation is not altered by heteromerization with UL33, UL78 or US27. (A, D and G) IP accumulation in HEK293 cells co-
expressing receptor heteromers. HEK293 cells were transiently transfected with Flag-US28 (75 ng/well) and either pcDNA3.1 (black bars, 75 ng/well) or 75 ng/well of HA-
UL33 (A), HA-UL78 (D) or HA-US27 (G), respectively (grey bars). Controls were transfected with either pcDNA3.1 alone (150 ng/well, white bars) or pcDNA3.1 (75 ng/well) in
combination with 75 ng/well of HA-UL33 (A), HA-UL78 (D) or HA-US27 (G) (striped bars) in the absence of Flag-US28. IP production mediated by US28 was allowed to
accumulate for 45 min. Values were normalized to the cell number, and 100% corresponds to the basal activity of US28 (black bars). Data are means of four experiments  SEM
carried out in quadruplicates. (B, C, E, F, H and I) Receptor expression levels evaluated by ELISA. HEK293 cells were transfected as described for the respective IP accumulation assay.
The expression levels of US28 were assayed by ELISA against the Flag epitope tag of US28 (B, E and H). The levels of UL33 (C), UL78 (F) and US27 (I) were assessed by ELISA against the
HA epitope tag of the respective receptors. Values were normalized to the cell number. Data are means  SEM of four independent experiments carried out in quadruplicates.
P. Tschische et al. / Biochemical Pharmacology 82 (2011) 610–619616[35,36], whereby the CCR5/CXCR4 heteromer was causally
involved in the modulation of T lymphocyte responses [37].
Moreover, homomerization of CCR5 was shown to prevent
infection with HIV-1 [38].
In addition, orphan receptors were shown to be capable of
inﬂuencing the activity of non-orphan receptors through hetero-
merization. The orphan receptor GPR50, for example, was reported
to antagonize the functions of the melatonin MT1 receptor via
heteromerization. Heteromerization of GPR50 with the MT1
receptor prevented the agonist binding and G protein coupling
[23]. Moreover, it was found that the carboxy-terminus of GPR50 is
involved in these inhibitory effects. As opposed to the wild type
receptor, heteromerization with a carboxy-terminally deleted
GPR50 did not alter MT1 related functions [23].
To evaluate the functional consequences of viral HCMV receptor
heteromerization, the Gaq/PLC/IP pathway and the activation ofthe downstream transcription factor NF-kB were monitored.
Surprisingly, the IP accumulation was not altered upon co-
expression of US28 with the orphan receptors (Fig. 4). On the
other hand, the constitutive activation of NF-kB was almost
completely blocked by the co-expression of UL33 (Fig. 5A) and
UL78 (Fig. 5D). US27, the HCMV encoded receptor that shares the
highest sequence homology with US28, did neither alter the IP
accumulation (Fig. 4G), nor the activation of the transcription
factor (Fig. 5G).
The NF-kB pathway is known to be an important regulator of
the innate and the adaptive immune response, inﬂammation and
cell survival [39]. The major immediate early promoter (MIEP)
region of HCMV, which controls the expression of immediate early
(IE) genes, contains four binding sites for the transcription factor
NF-kB. The role of these binding sites is not completely
established. In some studies, inhibition of NF-kB signaling yielded
Fig. 5. UL33 and UL78 alter US28 mediated NF-kB activation. (A, D and G) NF-kB activation in HEK293 cells co-expressing receptor heteromers. HEK293 cells were transiently
transfected with Flag-US28 (75 ng/well), the cis-reporter luciferase plasmid for NF-kB (50 ng/well) and either pcDNA3.1 (black bars, 75 ng/well) or 75 ng/well of HA-UL33 (A),
HA-UL78 (D) or HA-US27 (G), respectively (grey bars). Controls were transfected with either pcDNA3.1 alone (150 ng/well, white bars) or pcDNA3.1 (75 ng/well) in
combination with 75 ng/well of HA-UL33 (A), HA-UL78 (D) or HA-US27 (G) (striped bars) in the absence of Flag-US28. A luciferase reporter assay was conducted 24 h post-
transfection. Values were normalized to the cell number, whereby 100% corresponds to the basal activity of US28 (black bars). Data are means of three independent
experiments  SEM carried out in quadruplicates. ***p < 0.001. (B, C, E, F, H and I) Receptor expression levels evaluated by ELISA. HEK293 cells were transfected as described for the
respective NF-kB assay. The expression levels of US28 were assayed by ELISA against the Flag epitope tag of US28 (B, E and H). The levels of UL33 (C), UL78 (F) and US27 (I) were
assessed by ELISA against the HA epitope tag of the respective receptors. Values were normalized to the cell number. Data are means  SEM of four independent experiments carried
out in quadruplicates.
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that the deletion of the binding sites within the MIEP region had no
effects [42,43]. The mechanisms employed by HCMV for the
establishment of viral latency and reactivation are still an
important source of speculation. In general, HCMV infection and
reactivation were shown to yield the enhancement of cellular
responses, including the activation of transcription factors,
accumulation of cAMP, inositol phosphate hydrolysis and the
metabolism of arachidonic acid [44,45]. For g-herpesviruses, such
as KSHV (Kaposi’s sarcoma-associated herpesvirus), EBV (Epstein-
Barr virus) or g-herpesvirus 68 (g-HV68), the NF-kB pathway was
reported to be involved in cell growth as well as in the
establishment of viral latency [46–50]. Hence, it is tempting to
speculate that the selective modulation of the NF-kB activation via
heteromerization with US28 might be important in viral reactiva-
tion or latency. Indeed, heteromerization of US28 and UL78, which
is co-expressed during the early phases of HCMV infection, couldprovide a way to downregulate the NF-kB activation of US28. In
addition, during late stages of HCMV infection, the constitutive
activity of US28 could be modulated via heteromerization with
UL33. After the initial re-programming of newly infected cells, the
downregulation of US28 via heteromerization with the orphan
receptors UL33 and UL78 might thus represent a mechanism to
negatively modulate the NF-kB pathway.
Recent reports suggest that US28 might play a causative role in
multiple diseases associated with HCMV infection. Human
cytomegalovirus has been shown to be present in various
malignancies, including breast cancer [51], colon cancer [52] or
malignant glioblastoma [53]. Indeed, US28 seems to be involved
in tumorigenesis via the up-regulation of COX-2 [54,55].
Moreover, Bongers et al. showed that the receptor also promotes
intestinal neoplasia and cancer in transgenic mice [56]. In
addition, US28 might also represent the causative link between
HCMV infection and the accelerated progression of vascular
P. Tschische et al. / Biochemical Pharmacology 82 (2011) 610–619618diseases, since it is able to mediate the migration of vascular
smooth muscle cells [57].
Hence, the ﬁnding that US28 is engaged in hetero-/oligomeric
complexes provides important information for future drug design.
Furthermore, the manipulation of the NF-kB pathway via
heteromerization with the other HCMV encoded receptors might
contribute to understanding the mechanisms underlying viral
latency and reactivation in vivo.
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